The global demand for Biobanking Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.
Biobanking refers to a collection of biological samples and health information. Different biobank collects different types of information and samples some are specific to a particular disease or specific research while some are population based. The collected samples are associated with a list of data describing sample history, sampling method, sample treatment, and the analysis outcomes and are used for the development of new treatments or new technologies and scientific publications. There are several types of biobanks: disease-centric, population-based, DNA/RNA, tissue versus multiple specimen type, commercial, project-driven, and virtual biobanks.
Growing clinical trials and research in the healthcare and changing needs of investigators is estimated to drive the market. Biobanking is evolving as a potential field as precise and accurate collection of outcomes plays an important role in a multitude of studies. The evolving growth is provided by growing research in the field of genomics, proteomics, and personalised medicine. Biobanks have experienced a huge rise in the number of samples specifically requested for companion diagnostic and biomarker. In response to growing demand, biobanks and tissue suppliers have grown exponentially in both size and number, and are now establishing as a key partner for academic and commercial groups. Meanwhile, issues associated with biospecimen sample procurement and high cost of automation is hampering the growth of the market.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of biobanking.
The entire biobanking market has been sub-categorized into product, sample, and application. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
- Blood Products
- Human Tissues
- Cell Lines
- Nucleic Acids
- Regenerative Medicine
- Life Science
- Clinical Research
This section covers regional segmentation which accentuates on current and future demand for biobanking market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Biobanking Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the biobanking market include Thermo Fisher Scientific Inc., Panasonic Healthcare Holdings Co., Ltd., Becton, Dickinson and Company, Qiagen N.V., and Merck KGaA. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.